Published in PLoS One on October 12, 2010
The Peripheral NK Cell Repertoire after Kidney Transplantation is Modulated by Different Immunosuppressive Drugs. Front Immunol (2013) 0.89
PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenet Genomics (2013) 0.89
Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition. PLoS One (2013) 0.82
NKG2D and its ligands: active factors in the outcome of solid organ transplantation? Kidney Int Suppl (2011) (2011) 0.79
Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice. Sci Rep (2016) 0.79
Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies. Front Immunol (2016) 0.77
STAT4-associated natural killer cell tolerance following liver transplantation. Gut (2016) 0.77
Immune profiling and cancer post transplantation. World J Nephrol (2015) 0.77
Invasive aspergillosis in a renal transplant recipient successfully treated with interferon-gamma. Case Rep Transplant (2012) 0.76
Immune Parameters of Korean Patients with Psoriasis Treated with Low-Dose Cyclosporine. Ann Dermatol (2017) 0.75
Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients. Lupus Sci Med (2016) 0.75
Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation. Front Immunol (2017) 0.75
Natural Killer Cell Subsets and IL-2, IL-15, and IL-18 Genes Expressions in Chronic Kidney Allograft Dysfunction and Graft Function in Kidney Allograft Recipients. Int J Organ Transplant Med (2016) 0.75
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (2002) 12.75
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet (2007) 11.06
Functions of natural killer cells. Nat Immunol (2008) 9.88
Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol (2008) 7.88
Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med (1989) 7.52
Human natural killer cells. Blood (2008) 7.37
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature (1998) 7.12
CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods (2004) 6.89
ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity (2001) 5.42
Reshaping human antibodies for therapy. Nature (1988) 4.82
CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia (2005) 3.43
NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med (2006) 2.45
CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol (2001) 2.13
Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice. Nature (1977) 2.05
Relationship between CD107a expression and cytotoxic activity. Cell Immunol (2008) 1.95
Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet (1992) 1.72
Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia. Leukemia (2004) 1.60
Regulation of ligands for the activating receptor NKG2D. Immunology (2007) 1.55
Xenogeneic transplantation. Annu Rev Immunol (1998) 1.48
Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol (2006) 1.48
NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med (2005) 1.45
Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60. Immunity (2001) 1.43
The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations. Blood (2007) 1.39
The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol (2008) 1.29
Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood (2008) 1.28
Inhibition of human natural killer activity by cyclosporin A. Transplantation (1981) 1.22
Complex interactions: the immunogenetics of human leukocyte antigen and killer cell immunoglobulin-like receptors. Semin Hematol (2005) 1.19
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function. Transplantation (2008) 1.15
Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol Rev (1998) 1.10
Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation. Am J Transplant (2008) 1.10
Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab. Blood (2002) 1.09
Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H. Immunology (1996) 0.99
Heightened expression of the cytotoxicity receptor NKG2D correlates with acute and chronic nephropathy after kidney transplantation. Am J Transplant (2006) 0.96
Effect of in vitro cyclosporin. A treatment on human natural and antibody-dependent cell-mediated cytotoxicity. Transplantation (1983) 0.95
Natural killer cells and their role in graft rejection. Curr Opin Immunol (1998) 0.90
Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period? J Urol (2000) 0.84
Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro. Transplantation (1991) 0.84
Activation of alloreactive natural killer cells is resistant to cyclosporine. Transplantation (1997) 0.84
Calcineurin-dependent lytic granule exocytosis in NK-92 natural killer cells. Cell Immunol (2008) 0.83
Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine. Transplantation (2006) 0.83
Effective oral administration of tacrolimus in renal transplant recipients. Clin Transplant (2001) 0.82
Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function. Cytotherapy (2008) 0.81
Clonal CD8+ and CD52- T cells are induced in responding B cell lymphoma patients treated with Campath-1H (anti-CD52). Eur J Haematol (1997) 0.81
Evidence that early acute renal failure may be mediated by CD3- CD16+ cells in a kidney graft recipient with large granular lymphocyte proliferation. Transplantation (1992) 0.80
A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature (2005) 6.31
DNA repair is limiting for haematopoietic stem cells during ageing. Nature (2007) 4.71
Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med (2008) 4.24
Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production. Nat Immunol (2009) 2.29
Themis is a member of a new metazoan gene family and is required for the completion of thymocyte positive selection. Nat Immunol (2009) 1.84
Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat Genet (2013) 1.82
DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med (2011) 1.79
Detection of polyomavirus BK reactivation after renal transplantation using an intensive decoy cell surveillance program is cost-effective. Transplantation (2011) 1.52
CLEC-2 activates Syk through dimerization. Blood (2010) 1.49
DOCK8 is essential for T-cell survival and the maintenance of CD8+ T-cell memory. Eur J Immunol (2011) 1.46
Genetic analysis of autoimmune type 1 diabetes mellitus in mice. 1991. J Immunol (2014) 1.37
DOCK8 is critical for the survival and function of NKT cells. Blood (2013) 1.17
Unlocking the bottleneck in forward genetics using whole-genome sequencing and identity by descent to isolate causative mutations. PLoS Genet (2013) 1.14
MyD88-dependent autoimmune disease in Lyn-deficient mice. Eur J Immunol (2007) 1.11
B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2A. J Exp Med (2012) 1.10
Identification of a Steap3 endosomal targeting motif essential for normal iron metabolism. Blood (2008) 1.05
Factors affecting graft and patient survival after live donor kidney transplantation in the UK. Transplantation (2010) 1.04
Limited peripheral T cell anergy predisposes to retinal autoimmunity. J Immunol (2007) 1.00
The platelet receptor CLEC-2 is active as a dimer. Biochemistry (2009) 1.00
NF-κB regulates MICA gene transcription in endothelial cell through a genetically inhibitable control site. J Biol Chem (2011) 1.00
Lipopolysaccharide-activated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells. J Immunol (2008) 0.99
The crystal structure and mutational binding analysis of the extracellular domain of the platelet-activating receptor CLEC-2. J Biol Chem (2006) 0.98
Increased positive selection of B1 cells and reduced B cell tolerance to intracellular antigens in c1q-deficient mice. J Immunol (2007) 0.96
The essential role of DOCK8 in humoral immunity. Dis Markers (2010) 0.94
Crystallization and X-ray diffraction analysis of human CLEC-2. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.93
Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival. Eur J Immunol (2005) 0.92
PeaKDEck: a kernel density estimator-based peak calling program for DNaseI-seq data. Bioinformatics (2014) 0.89
The phenotype of circulating follicular-helper T cells in patients with rheumatoid arthritis defines CD200 as a potential therapeutic target. Clin Dev Immunol (2012) 0.89
Impaired lymphocyte development and antibody class switching and increased malignancy in a murine model of DNA ligase IV syndrome. J Clin Invest (2009) 0.89
CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions. J Immunol (2006) 0.89
Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2D. J Immunol (2002) 0.89
The cellular location of self-antigen determines the positive and negative selection of autoreactive B cells. J Exp Med (2003) 0.89
Structural flexibility of the macrophage dengue virus receptor CLEC5A: implications for ligand binding and signaling. J Biol Chem (2011) 0.89
Floating-Harbor syndrome and polycystic kidneys associated with SRCAP mutation. Am J Med Genet A (2012) 0.88
Spontaneous B cell hyperactivity in autoimmune-prone MRL mice. Int Immunol (2006) 0.87
A whole blood monokine-based reporter assay provides a sensitive and robust measurement of the antigen-specific T cell response. J Transl Med (2011) 0.86
Tetrameric complexes of HLA-E, HLA-F, and HLA-G. J Immunol Methods (2002) 0.85
B-cell tolerance. Transplantation (2006) 0.83
Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology. Brain (2013) 0.82
Critical Role for an acidic amino acid region in platelet signaling by the HemITAM (hemi-immunoreceptor tyrosine-based activation motif) containing receptor CLEC-2 (C-type lectin receptor-2). J Biol Chem (2012) 0.81
Detection of BK virus in urine from renal transplant subjects by mass spectrometry. Clin Proteomics (2012) 0.79
Crystallization and X-ray diffraction analysis of human CLEC5A (MDL-1), a dengue virus receptor. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.79
Spontaneous class switching and B cell hyperactivity increase autoimmunity against intracellular self antigen in Lyn-deficient mice. Eur J Immunol (2006) 0.78
Signals from a self-antigen induce positive selection in early B cell ontogeny but are tolerogenic in adults. J Immunol (2006) 0.78
The high-risk corneal regraft model: a justification for tissue matching in humans. Transpl Int (2013) 0.77
Isotype control of B cell signaling. Sci STKE (2003) 0.77
The impact of the quality of communication from nephrologists to primary care practitioners: a literature review. Curr Med Res Opin (2014) 0.76
TLR4, TLR9 and MyD88 are not required for the positive selection of autoreactive B cells into the primary repertoire. Eur J Immunol (2006) 0.76
Impact of routine reporting of estimated glomerular filtration rate using the CKD-EPI formula in a community population: A cross-sectional cohort study. Nephrology (Carlton) (2014) 0.76
Molecular analysis of the interaction of the snake venom rhodocytin with the platelet receptor CLEC-2. Toxins (Basel) (2011) 0.76
Diagnostic Accuracies of Glycated Hemoglobin, Fructosamine, and Homeostasis Model Assessment of Insulin Resistance in Predicting Impaired Fasting Glucose, Impaired Glucose Tolerance, or New Onset Diabetes After Transplantation. Transplantation (2016) 0.76
Tolerance and autoimmunity in the eye: a role for CD8 T cells in organ-specific autoimmunity in the retina. Immunology (2003) 0.75
Next-generation sequencing to dissect hereditary nephrotic syndrome in mice identifies a hypomorphic mutation in Lamb2 and models Pierson's syndrome. J Pathol (2014) 0.75
Impact on cardiovascular risk follow-up from a shift to the CKD-EPI formula for eGFR reporting: a cross-sectional population-based primary care study. BMJ Open (2013) 0.75
Expression, purification and crystallization of the human UL16-binding protein ULBP1. Protein Expr Purif (2011) 0.75
Analysis of B-cell immune tolerance induction using transgenic mice. Methods Mol Biol (2004) 0.75